Skip to content

NIR- and Multifrequent Impedance Spectroscopy on the Skin in Type 1 Diabetes

NIR (Near Infrared)- Spectroscopy and Multifrequent Impedance Spectroscopy on the Skin to Detection of Sensory and Autonomic Neuropathy Among Patients With Type 1 Diabetes

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01707979
Acronym
NIR
Enrollment
30
Registered
2012-10-16
Start date
2012-09-30
Completion date
2012-10-31
Last updated
2012-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Neuropathy

Keywords

Near infrared light, Diabetic neuropathy, Sensory neuropathy, Autonomic neuropathy, Vagus, Sudomotor function, Monofilament, Impedance

Brief summary

The aim of the study is to examine the suitability to detect diabetic neuropathy using NIR and impedance.

Detailed description

The aim of the study is to examine how suitable a hand-held measuring probe (DDD-probe) using NIR (near infrared light) as well as impedance (conductivity), is to detect early signs of diabetic neuropathy. The DDD-probe is put directly on the skin and is measuring by the use of light and impedance.

Interventions

None listed

Sponsors

Lise Tarnow
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
MALE
Age
35 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* men with type 1 diabetes (WHO criteria) * age 35-50 years * duration of diabetes \> 10 years

Exclusion criteria

* P-creatinine\> 120 micromol/l * other acute or chronic disease, or type of treatment that makes the patient unsuitable to participate, valuated by the investigator * non intact skin on the measuring spots * the patient is unable to understand the informed consent

Design outcomes

Primary

MeasureTime frameDescription
near infrared spectroscopyone timeNear infrared (NIR) is measured by spectroscopy on the skin using the DDD probe

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026